These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22023049)

  • 1. Editorial: Gold derivatives as anti-cancer agents.
    Raurell LR
    Anticancer Agents Med Chem; 2011 Dec; 11(10):920. PubMed ID: 22023049
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action.
    Lima JC; Rodriguez L
    Anticancer Agents Med Chem; 2011 Dec; 11(10):921-8. PubMed ID: 21864238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(III) complexes in medicinal chemistry.
    Maia PI; Deflon VM; Abram U
    Future Med Chem; 2014 Sep; 6(13):1515-36. PubMed ID: 25365235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Activity of Alkynylgold(I) with P(NMe
    Abas E; Espallargas N; Burbello G; Mesonero JE; Rodriguez-Dieguez A; Grasa L; Laguna M
    Inorg Chem; 2019 Nov; 58(22):15536-15551. PubMed ID: 31697068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for the biological evaluation of gold anticancer agents.
    Fricker SP
    Anticancer Agents Med Chem; 2011 Dec; 11(10):940-52. PubMed ID: 21864236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer gold(I) phosphine complexes: Cyclic trimers and tetramers containing the P-Au-P moiety.
    Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
    J Inorg Biochem; 2017 Oct; 175():1-8. PubMed ID: 28686996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and proposed targets for selected anticancer gold compounds.
    Casini A; Messori L
    Curr Top Med Chem; 2011; 11(21):2647-60. PubMed ID: 22039866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
    Arcau J; Andermark V; Aguiló E; Gandioso A; Moro A; Cetina M; Lima JC; Rissanen K; Ott I; Rodríguez L
    Dalton Trans; 2014 Mar; 43(11):4426-36. PubMed ID: 24302256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
    Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
    Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal complexes, their cellular targets and potential for cancer therapy.
    Chen D; Milacic V; Frezza M; Dou QP
    Curr Pharm Des; 2009; 15(7):777-91. PubMed ID: 19275642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
    García-Moreno E; Gascón S; Atrián-Blasco E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
    Eur J Med Chem; 2014 May; 79():164-72. PubMed ID: 24732792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
    Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
    Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
    Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazole-based phosphane gold(I) complexes as potential agents for cancer treatment: synthesis, structural studies and antitumour activity.
    Kunz PC; Kassack MU; Hamacher A; Spingler B
    Dalton Trans; 2009 Oct; (37):7741-7. PubMed ID: 19759948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
    Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
    Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.
    Bertrand B; Casini A
    Dalton Trans; 2014 Mar; 43(11):4209-19. PubMed ID: 24225667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.
    Gambini V; Tilio M; Maina EW; Andreani C; Bartolacci C; Wang J; Iezzi M; Ferraro S; Ramadori AT; Simon OC; Pucciarelli S; Wu G; Dou QP; Marchini C; Galassi R; Amici A
    Eur J Med Chem; 2018 Jul; 155():418-427. PubMed ID: 29906688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
    Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
    Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
    Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Au20 nanocluster protected by hemilabile phosphines.
    Wan XK; Lin ZW; Wang QM
    J Am Chem Soc; 2012 Sep; 134(36):14750-2. PubMed ID: 22931402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.